Zolpidem Tartrate
Product manufactured by Par Pharmaceutical, Inc.
Indications and Purposes
| 1 Indications And Usage Zolpidem Tartrate Sublingual Tablets Are Indicated For The Short-Term Treatment Of Insomnia Characterized By Difficulties With Sleep Initiation [See Clinical Studies (14)] . The Clinical Trials Performed With Zolpidem Tartrate In Support Of Efficacy Were 4-5 Weeks In Duration With The Final Formal Assessments Of Sleep Latency Performed At The End Of Treatment. Zolpidem Tartrate Sublingual Tablets, A Gamma-Aminobutyric Acid (Gaba) A Receptor Positive Modulator, Is Indicated For The Short-Term Treatment Of Insomnia Characterized By Difficulties With Sleep Initiation. Zolpidem Tartrate Has Been Shown To Decrease Sleep Latency For Up To 35 Days In Controlled Clinical Studies. (1) |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Zolpidem Tartrate |
|
ZINC3876 |